- IL Therapeutics
Infobox_Company
company_name = IL Therapeutics Inc.
company_type =
foundation =
location =105E ñ 111 Research Drive, Saskatoon, SK,Canada
key_people =
industry =Biotechnology
num_employees =
products =
homepage =IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP(“Western Life Sciences”) and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation (“Pacgen”)Citation | last =Pacgen Biopharmaceuticals Corporation
first = | author-link = | last2 = | first2 = | author2-link = | title =Pacgen Biopharmaceuticals Acquires IL Therapeutics Inc. | date = | year = | url =http://www.pacgenbiopharm.com/investor/pdfs/news_release20060412.pdf | accessdate = Sept 9, 2007 ]History
Saskatchewan Research Council operates a bio-processing laboratory which facilitated biomedical research. IL Therapeutics was developed from research first begun at the Western College of Veterinary MedicinePharmaceuticals
Currently IL Therapeutics is working on a drug candidate, IL-8(3-73)K11R/G31P (“PAC-G31P”) for relief of Acute Respiratory Distress Syndrome (ARDS)Citation | last =Pacgen Biopharmaceuticals Corporation | first = | author-link = | last2 = | first2 = | author2-link =
title =Pacgen Biopharmaceuticals Acquires IL Therapeutics Inc. | date = | year =
url =http://www.pacgenbiopharm.com/investor/releases/20060412.html
accessdate = Sept 9, 2007 ] The Saskatchewan Research council, SRC also assisted with the funding of this project through the Agriculture Development Fund - SRC Industry Venture Fund.Citation | last =Saskatchewan Research Council 2005-2006 Annual Report
first = | author-link = | last2 = | first2 = | author2-link = | title =Sustainable Science Solutions
date = | year = | url =http://www.src.sk.ca/store/account/download_file.cfm?productID=3483&freeDownloadID=538
accessdate = Sept 9, 2007 ] The successful progression of G31PRecently theUniversity of Saskatchewan Industry Liaison Office (ILO) decided to commercialize a commercialize this new drug treatment.Citation | last =U of S News Releases: University Communication
first = | author-link = | last2 = | first2 = | author2-link =
title =U of S News Releases: U of S Signs Letter of Intent to Commercialize Treatment for Lung Injury Complications | date = | year = | url =http://announcements.usask.ca/news/archive/2004/05/u_of_s_signs_le.html
accessdate = Sept 9, 2007 ] This research has been sponsored by a $3 million boost from the Western Life Sciences Venture Fund (WLS)Citation | last =U of S News Releases: University Communication | first = | author-link = | last2 = | first2 = | author2-link =
title =U of S News Releases: U of S Spin-off gets $3 Million Boost to Develop Anti-inflammatory Drug
date = | year = | url =http://announcements.usask.ca/news/archive/2004/11/u_of_s_spinoff_2.html
accessdate = Sept 9, 2007 ]References
ee also
*
Biotechnology
*List of biotechnology companies
*Innovation Place Research Park
*University of Saskatchewan External links
* [http://www.usask.ca/research/news/read.php?id=592 University of Saskatchewan Research - Discovery @ U of S: May 24, 2006]
* [http://www.agwest.sk.ca/publications/documents/abbdec04.rtf AgBiotech Bulletin]
* [http://www.agwest.sk.ca/documents/abbdec04.pdf Europe and GMOs: the dance continues In this issue:]
* [http://announcements.usask.ca/news/archive/2004/11/ U of S News Releases: November 2004 Archives]
* [http://www.innovation.ca/publications/icur_dws_e.pdf Untitles]
* [http://www.usask.ca/wcvm/news/archivednews.php Western College of Veterinary Medicine]
Wikimedia Foundation. 2010.
